Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 -- The first clinical trial at the HUS BNCT facility is nearing completion HELSINKI ...
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in ...
Boron Neutron Capture Therapy (BNCT) is a targeted radiotherapeutic modality that exploits the nuclear reaction between boron-10 and low-energy thermal neutrons. This reaction produces high-linear ...
HSINCHU, Taiwan--(BUSINESS WIRE)--On February 14 th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the building of Tsing Hua Open pool Reactor (THOR) at ...
TAE Life Sciences (TLS), a leader in Boron Neutron Capture Therapy (BNCT), today announced key milestones demonstrating commercial traction, clinical adoption, and global supply chain development. The ...
HELSINKI and BOSTON, May 16, 2025 /PRNewswire/ -- Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital with ...
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumors in some cancers. Treatment for more advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results